"10.1371_journal.pone.0011143","plos one","2010-06-15T00:00:00Z","Nobuyuki Matoba; Adam S Husk; Brian W Barnett; Michelle M Pickel; Charles J Arntzen; David C Montefiori; Atsushi Takahashi; Kazunobu Tanno; Satoshi Omura; Huyen Cao; Jason P Mooney; Carl V Hanson; Haruo Tanaka","Owensboro Cancer Research Program, Owensboro, Kentucky, United States of America; Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, United States of America; Center for Infectious Diseases and Vaccinology, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America; Faculty of Pharmacy and College of Science and Engineering, Iwaki Meisei University, Fukushima, Japan; KIIM Pharmaceutical Laboratories, Inc., Fukushima, Japan; Kitasato Institute for Lifescience, Kitasato University, Tokyo, Japan; California Department of Public Health, Richmond, California, United States of America","Conceived and designed the experiments: NM CJA SO HT. Performed the experiments: NM ASH BWB MMP JPM. Analyzed the data: NM DCM HC CVH. Contributed reagents/materials/analysis tools: DCM AT KT HC CVH HT. Wrote the paper: NM.","H.T. and K.T. are members of KIIM Pharmaceutical Laboratories, Inc., which owns the intellectual properties and the commercialization rights of A.H.. H.T., S.O., K.T., and A.T. are listed as inventors on patent applications related to actinohivin. These conditions do not alter the authors adherence to PLoS ONE policies on sharing data and materials. Materials and information associated with the authors publication will be freely available to those as reasonably requested for the purpose of academic, non-commercial research.","2010","06","Nobuyuki Matoba","NM",13,TRUE,4,5,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
